Sevilla and Lleida, Spain, 2 December 2024 – Stirling Square Capital Partners (“Stirling Square”), a leading pan-European mid-market private equity firm, today announces that its portfolio company Sustainable Agro Solutions (“SAS”), a leading developer and producer of biostimulants, soil and water improvers, defence activators and specialty plant nutrition solutions for the agricultural sector, has acquired Pevesa Biotech’s Agroscience division (“Pevesa Agroscience”), the plant-based biostimulant and fertilizer producer, from Kerry Group plc, a leading provider of taste and nutrition solutions for the food,beverage and pharmaceutical sectors. Financial terms of the transaction have not been disclosed.

As part of the transaction, SAS will acquire Pevesa Agroscience’s operating assets and intellectual property, and ensure continuity for customers and employees. The transaction will enable the vertical integration of a strategic raw material – amino acids deriving from natural plant sources – and allow SAS to maximize its full potential. Stirling Square will work closely alongside SAS’s leadership team as they continue to deliver their strategy of developing the company into an international market leader in agricultural biosolutions.

Stirling Square acquired a majority stake in SAS in July 2021 and is supporting the company to grow both organically through R&D investments, product development and market expansion, as well as through M&A. In July 2023, SAS acquired Biovert, a leading biosolutions business. The acquisition of Pevesa Agroscience builds on strong momentum in SAS’ strategy, as it progresses a substantial project to expand its facilities in Lleida,Spain, to meet growing customer demand and support the business’ future growth.

‍Eduard Vallverdú, CEO of SAS said: “We have admired Pevesa Agroscience for a long time and are thrilled to announce this investment at an exciting time for our business. This transaction fits very well into SAS’ core business and will enable us to introduce Pevesa Agroscience’s complementary and differentiated technology, intellectual property, and operating assets to SAS. We will integrate into SAS a strategic raw material, allowing us to increase the efficiency, quality, and differentiation of the company’s biostimulants product portfolio. That will support our ambition to become a global leader in the development and production of biosolutions for the agricultural sector. We continue to explore new investment opportunities to supplement our organic growth as we look ahead.”